PUBLICATIONS

Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system

No.24
Year2016
JournalThrombosis and Haemostasis
InstituteDepartment of Medicine, Division of Hematology, Coagulation Unit, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
1st AuthorÅgren A
AR
PL
Paper typesClinical investigations
Main
purpose
Drug efficacy evaluation
DiseaseVWD type3
Antiplatelet drug
Anticoagulant drug
Other drug
Clinical specimens
Animal
Keyword
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2020 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.